Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Nicotine intake and smoking topography in smokers with bipolar disorder.

Williams JM, Gandhi KK, Lu SE, Steinberg ML, Benowitz NL.

Bipolar Disord. 2012 Sep;14(6):618-27. doi: 10.1111/j.1399-5618.2012.01047.x.

PMID:
22938167
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.

Williams JM, Gandhi KK, Benowitz NL.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2582-9. doi: 10.1158/1055-9965.EPI-10-0384. Epub 2010 Aug 18.

PMID:
20719908
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.

Williams JM, Gandhi KK, Lu SE, Kumar S, Steinberg ML, Cottler B, Benowitz NL.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):313-9. doi: 10.1016/j.drugalcdep.2011.04.009. Epub 2011 May 18.

PMID:
21596491
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect.

Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL.

Schizophr Res. 2005 Nov 15;79(2-3):323-35. Epub 2005 Jun 14.

PMID:
15961287
[PubMed - indexed for MEDLINE]
5.

Nicotine metabolite ratio as a predictor of cigarette consumption.

Benowitz NL, Pomerleau OF, Pomerleau CS, Jacob P 3rd.

Nicotine Tob Res. 2003 Oct;5(5):621-4.

PMID:
14577978
[PubMed - indexed for MEDLINE]
6.

CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.

Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1812-9.

PMID:
17035386
[PubMed - indexed for MEDLINE]
Free Article
7.

Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.

Jacob P 3rd, Yu L, Duan M, Ramos L, Yturralde O, Benowitz NL.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 1;879(3-4):267-76. doi: 10.1016/j.jchromb.2010.12.012. Epub 2010 Dec 21.

PMID:
21208832
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.

Benowitz NL, Swan GE, Jacob P 3rd, Lessov-Schlaggar CN, Tyndale RF.

Clin Pharmacol Ther. 2006 Nov;80(5):457-67.

PMID:
17112802
[PubMed - indexed for MEDLINE]
9.

Determinants of the rate of nicotine metabolism and effects on smoking behavior.

Johnstone E, Benowitz N, Cargill A, Jacob R, Hinks L, Day I, Murphy M, Walton R.

Clin Pharmacol Ther. 2006 Oct;80(4):319-30.

PMID:
17015050
[PubMed - indexed for MEDLINE]
10.

Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.

Ho MK, Mwenifumbo JC, Al Koudsi N, Okuyemi KS, Ahluwalia JS, Benowitz NL, Tyndale RF.

Clin Pharmacol Ther. 2009 Jun;85(6):635-43. doi: 10.1038/clpt.2009.19. Epub 2009 Mar 11.

PMID:
19279561
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.

Dempsey D, Tutka P, Jacob P 3rd, Allen F, Schoedel K, Tyndale RF, Benowitz NL.

Clin Pharmacol Ther. 2004 Jul;76(1):64-72.

PMID:
15229465
[PubMed - indexed for MEDLINE]
12.

Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.

Nagano T, Shimizu M, Kiyotani K, Kamataki T, Takano R, Murayama N, Shono F, Yamazaki H.

Int J Environ Res Public Health. 2010 Jul;7(7):2953-64. doi: 10.3390/ijerph7072953. Epub 2010 Jul 20.

PMID:
20717551
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.

Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, Yokoi T.

Clin Pharmacol Ther. 2006 Sep;80(3):282-97.

PMID:
16952495
[PubMed - indexed for MEDLINE]
14.

Accelerated metabolism of nicotine and cotinine in pregnant smokers.

Dempsey D, Jacob P 3rd, Benowitz NL.

J Pharmacol Exp Ther. 2002 May;301(2):594-8.

PMID:
11961061
[PubMed - indexed for MEDLINE]
Free Article
15.

Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia.

Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL.

Nicotine Tob Res. 2007 Aug;9(8):873-81.

PMID:
17654300
[PubMed - indexed for MEDLINE]
16.
17.

Female sex and oral contraceptive use accelerate nicotine metabolism.

Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd.

Clin Pharmacol Ther. 2006 May;79(5):480-8.

PMID:
16678549
[PubMed - indexed for MEDLINE]
18.

Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.

Hukkanen J, Jacob P 3rd, Benowitz NL.

Clin Pharmacol Ther. 2006 Nov;80(5):522-30.

PMID:
17112808
[PubMed - indexed for MEDLINE]
19.

Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers.

Berlin I, Gasior MJ, Moolchan ET.

Nicotine Tob Res. 2007 Apr;9(4):493-8.

PMID:
17454704
[PubMed - indexed for MEDLINE]
20.

The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.

Sellers EM, Ramamoorthy Y, Zeman MV, Djordjevic MV, Tyndale RF.

Nicotine Tob Res. 2003 Dec;5(6):891-9.

PMID:
14668073
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk